A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
Clinical trial NCT07607678 · RECRUITING
Trial details
- NCT number
- NCT07607678
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-06-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.